Heyam Hayder
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Heyam Hayder has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Chun Peng
Department of Biology, York University, Toronto, ON, Canada
5 shared publications - Caroline Dunk
Departments of Physiology and Obstetrics and Gynecology, Women's and Infant's Health, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada
2 shared publications Chun Peng
Department of Biology and Centre for Research on Biomolecular Interactions, York University , 4700 Keele Street, Toronto, Ontario M3J 1P3, Canada
2 shared publications- Jacob O'BRien
Department of Biology, York University, Toronto, ON M3J 1P3, Canada
2 shared publications - Lubna Nadeem
Luneneld-Tanenbaum Research Institute, Sinai Health, Toronto, Canada
2 shared publications - Stephen James Lye
Department of Physiology, University of Toronto, Toronto, ON M5S 1A8, Canada
2 shared publications
Latest Publications
- Open Access
WITHDRAWN: Truncated NLRC5 isoforms in human placenta: expression, regulation by miR-218-5p, and function in trophoblasts
A key event during placenta development is the differentiation of trophoblast progenitor cells into the invasive extravillous trophoblasts (EVTs) that migrate into the uterus. A subset of EVTs further acquire endothelial-like properties and differentiate into endovascular EVTs (enEVTs) to remodel the maternal spiral arteries. Proper EVT differentiation, migration/invasion, and spiral artery remodeling are critical for a healthy pregnancy. We recently reported that hsa-miR-218-5p promotes EVT/enEVT differentiation and spiral artery remodeling. In this study, we further investigated the mechanisms underlying the actions of miR-218-5p in human trophoblasts and identified NLRC5 as a target gene of miR-218-5p. Interestingly, we found that the human placenta expresses predominantly two transcript variants (v22 and v23) of the human NLRC5 gene, which encode two truncated protein isoforms 17 and 18 (i17 and i18). The expression of these isoforms declined during the active period of spiral artery remodeling. In vitro and ex vivo studies revealed that overexpression of v22 or v23 suppressed, while silencing of v22/23 enhanced, cell migration, invasion, endothelial-like network formation, and enEVT marker expression, as well as the EVT outgrowth of first trimester placental explants. Mechanistically, i17 and i18 regulated trophoblast activity by inhibiting NFκB. These findings suggest that NLRC5 isoforms are important regulators of EVT/enEVT differentiation and/or function, highlighting a novel miR-218-5p/NLRC5/NFκB signaling axis in placental development.
Open AccessWITHDRAWN: Truncated NLRC5 isoforms in human placenta: expression, regulation by miR-218-5p, and function in trophoblasts
A key event during placenta development is the differentiation of trophoblast progenitor cells into the invasive extravillous trophoblasts (EVTs) that migrate into the uterus. A subset of EVTs further acquire endothelial-like properties and differentiate into endovascular EVTs (enEVTs) to remodel the maternal spiral arteries. Proper EVT differentiation, migration/invasion, and spiral artery remodeling are critical for a healthy pregnancy. We recently reported that hsa-miR-218-5p promotes EVT/enEVT differentiation and spiral artery remodeling. In this study, we further investigated the mechanisms underlying the actions of miR-218-5p in human trophoblasts and identified NLRC5 as a target gene of miR-218-5p. Interestingly, we found that the human placenta expresses predominantly two transcript variants (v22 and v23) of the human NLRC5 gene, which encode two truncated protein isoforms 17 and 18 (i17 and i18). The expression of these isoforms declined during the active period of spiral artery remodeling. In vitro and ex vivo studies revealed that overexpression of v22 or v23 suppressed, while silencing of v22/23 enhanced, cell migration, invasion, endothelial-like network formation, and enEVT marker expression, as well as the EVT outgrowth of first trimester placental explants. Mechanistically, i17 and i18 regulated trophoblast activity by inhibiting NFκB. These findings suggest that NLRC5 isoforms are important regulators of EVT/enEVT differentiation and/or function, highlighting a novel miR-218-5p/NLRC5/NFκB signaling axis in placental development.
- Open Access
- 18 July 2022
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 227 (4) , 641.e1-641.e13
Human leukocyte antigen HLA-C, HLA-G, HLA-F, and HLA-E placental profiles are altered in early severe preeclampsia and preterm birth with chorioamnionitis
- 18 July 2022
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 227 (4) , 641.e1-641.e13
Open AccessHuman leukocyte antigen HLA-C, HLA-G, HLA-F, and HLA-E placental profiles are altered in early severe preeclampsia and preterm birth with chorioamnionitis
- Open Access
- 12 April 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (8) , 3961
Overexpression of miR-210-3p Impairs Extravillous Trophoblast Functions Associated with Uterine Spiral Artery Remodeling
Hsa-miR-210-3p has been reported to be upregulated in preeclampsia (PE); however, the functions of miR-210-3p in placental development are not fully understood, and, consequently, miR-210-3p’s role in the pathogenesis of PE is still under investigation. In this study, we found that overexpression of miR-210-3p reduced trophoblast migration and invasion, extravillous trophoblast (EVT) outgrowth in first trimester explants, expression of endovascular trophoblast (enEVT) markers and the ability of trophoblast to form endothelial-like networks. In addition, miR-210-3p overexpression significantly downregulated the mRNA levels of interleukin-1B and -8, as well as CXC motif ligand 1. These cytokines have been suggested to play a role in EVT invasion and the recruitment of immune cells to the spiral artery remodeling sites. We also showed that caudal-related homeobox transcription factor 2 (CDX2) is targeted by miR-210-3p and that CDX2 downregulation mimicked the observed effects of miR-210-3p upregulation in trophoblasts. These findings suggest that miR-210-3p may play a role in regulating events associated with enEVT functions and its overexpression could impair spiral artery remodeling, thereby contributing to PE.
- 12 April 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (8) , 3961
Open AccessOverexpression of miR-210-3p Impairs Extravillous Trophoblast Functions Associated with Uterine Spiral Artery Remodeling
Hsa-miR-210-3p has been reported to be upregulated in preeclampsia (PE); however, the functions of miR-210-3p in placental development are not fully understood, and, consequently, miR-210-3p’s role in the pathogenesis of PE is still under investigation. In this study, we found that overexpression of miR-210-3p reduced trophoblast migration and invasion, extravillous trophoblast (EVT) outgrowth in first trimester explants, expression of endovascular trophoblast (enEVT) markers and the ability of trophoblast to form endothelial-like networks. In addition, miR-210-3p overexpression significantly downregulated the mRNA levels of interleukin-1B and -8, as well as CXC motif ligand 1. These cytokines have been suggested to play a role in EVT invasion and the recruitment of immune cells to the spiral artery remodeling sites. We also showed that caudal-related homeobox transcription factor 2 (CDX2) is targeted by miR-210-3p and that CDX2 downregulation mimicked the observed effects of miR-210-3p upregulation in trophoblasts. These findings suggest that miR-210-3p may play a role in regulating events associated with enEVT functions and its overexpression could impair spiral artery remodeling, thereby contributing to PE.
- Top Cited PapersOpen Access
- 3 August 2018
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 9, 402
Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation
MicroRNAs (miRNAs) are a class of non-coding RNAs that play important roles in regulating gene expression. The majority of miRNAs are transcribed from DNA sequences into primary miRNAs and processed into precursor miRNAs, and finally mature miRNAs. In most cases, miRNAs interact with the 3′ untranslated region (3′ UTR) of target mRNAs to induce mRNA degradation and translational repression. However, interaction of miRNAs with other regions, including the 5′ UTR, coding sequence, and gene promoters, have also been reported. Under certain conditions, miRNAs can also activate translation or regulate transcription. The interaction of miRNAs with their target genes is dynamic and dependent on many factors, such as subcellular location of miRNAs, the abundancy of miRNAs and target mRNAs, and the affinity of miRNA-mRNA interactions. miRNAs can be secreted into extracellular fluids and transported to target cells via vesicles, such as exosomes, or by binding to proteins, including Argonautes. Extracellular miRNAs function as chemical messengers to mediate cell-cell communication. In this review, we provide an update on canonical and non-canonical miRNA biogenesis pathways and various mechanisms underlying miRNA-mediated gene regulations. We also summarize the current knowledge of the dynamics of miRNA action and of the secretion, transfer, and uptake of extracellular miRNAs.
- 3 August 2018
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 9, 402
Top Cited PapersOpen AccessOverview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation
MicroRNAs (miRNAs) are a class of non-coding RNAs that play important roles in regulating gene expression. The majority of miRNAs are transcribed from DNA sequences into primary miRNAs and processed into precursor miRNAs, and finally mature miRNAs. In most cases, miRNAs interact with the 3′ untranslated region (3′ UTR) of target mRNAs to induce mRNA degradation and translational repression. However, interaction of miRNAs with other regions, including the 5′ UTR, coding sequence, and gene promoters, have also been reported. Under certain conditions, miRNAs can also activate translation or regulate transcription. The interaction of miRNAs with their target genes is dynamic and dependent on many factors, such as subcellular location of miRNAs, the abundancy of miRNAs and target mRNAs, and the affinity of miRNA-mRNA interactions. miRNAs can be secreted into extracellular fluids and transported to target cells via vesicles, such as exosomes, or by binding to proteins, including Argonautes. Extracellular miRNAs function as chemical messengers to mediate cell-cell communication. In this review, we provide an update on canonical and non-canonical miRNA biogenesis pathways and various mechanisms underlying miRNA-mediated gene regulations. We also summarize the current knowledge of the dynamics of miRNA action and of the secretion, transfer, and uptake of extracellular miRNAs.
- Open Access
- 1 June 2018
- Published by Oxford University Press (OUP) in Reproduction
- Vol. 155 (6) , R259-R271
MicroRNAs: crucial regulators of placental development
MicroRNAs (miRNAs) are small non-coding single-stranded RNAs that are integral to a wide range of cellular processes mainly through the regulation of translation and mRNA stability of their target genes. The placenta is a transient organ that exists throughout gestation in mammals, facilitating nutrient and gas exchange and waste removal between the mother and the fetus. miRNAs are expressed in the placenta, and many studies have shown that miRNAs play an important role in regulating trophoblast differentiation, migration, invasion, proliferation, apoptosis, vasculogenesis/angiogenesis and cellular metabolism. In this review, we provide a brief overview of canonical and non-canonical pathways of miRNA biogenesis and mechanisms of miRNA actions. We highlight the current knowledge of the role of miRNAs in placental development. Finally, we point out several limitations of the current research and suggest future directions.
- 1 June 2018
- Published by Oxford University Press (OUP) in Reproduction
- Vol. 155 (6) , R259-R271
Open AccessMicroRNAs: crucial regulators of placental development
MicroRNAs (miRNAs) are small non-coding single-stranded RNAs that are integral to a wide range of cellular processes mainly through the regulation of translation and mRNA stability of their target genes. The placenta is a transient organ that exists throughout gestation in mammals, facilitating nutrient and gas exchange and waste removal between the mother and the fetus. miRNAs are expressed in the placenta, and many studies have shown that miRNAs play an important role in regulating trophoblast differentiation, migration, invasion, proliferation, apoptosis, vasculogenesis/angiogenesis and cellular metabolism. In this review, we provide a brief overview of canonical and non-canonical pathways of miRNA biogenesis and mechanisms of miRNA actions. We highlight the current knowledge of the role of miRNAs in placental development. Finally, we point out several limitations of the current research and suggest future directions.
- 4 April 2017
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 89 (8) , 4743-4748
Accurate MicroRNA Analysis in Crude Cell Lysate by Capillary Electrophoresis-Based Hybridization Assay in Comparison with Quantitative Reverse Transcription-Polymerase Chain Reaction
Accurate quantitation of microRNA (miRNA) in tissue samples is required for validation and clinical use of miRNA-based disease biomarkers. Since sample processing, such as RNA extraction, introduces undesirable biases, it is advantageous to measure miRNA in a crude cell lysate. Here, we report on accurate miRNA quantitation in crude cell lysate by a CE-based hybridization assay termed direct quantitative analysis of multiple miRNAs (DQAMmiR). Accuracy and precision of miRNA quantitation were determined for miRNA samples in a crude cell lysate, RNA extract from the lysate, and a pure buffer. The results showed that the measurements were matrix-independent with inaccuracies of below 13% from true values and relative standard deviations of below 11% from the mean values in a miRNA concentration range of 2 orders of magnitude. We compared DQAMmiR-derived results with those obtained by a benchmark miRNA-quantitation method–quantitative reverse transcription-polymerase chain reaction (qRT-PCR). qRT-PCR-based measurements revealed multifold inaccuracies and relative standard deviations of up to 70% in crude cell lysate. Robustness of DQAMmiR to changes in sample matrix makes it a perfect candidate for validation and clinical use of miRNA-based disease biomarkers.
- 4 April 2017
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 89 (8) , 4743-4748
Accurate MicroRNA Analysis in Crude Cell Lysate by Capillary Electrophoresis-Based Hybridization Assay in Comparison with Quantitative Reverse Transcription-Polymerase Chain Reaction
Accurate quantitation of microRNA (miRNA) in tissue samples is required for validation and clinical use of miRNA-based disease biomarkers. Since sample processing, such as RNA extraction, introduces undesirable biases, it is advantageous to measure miRNA in a crude cell lysate. Here, we report on accurate miRNA quantitation in crude cell lysate by a CE-based hybridization assay termed direct quantitative analysis of multiple miRNAs (DQAMmiR). Accuracy and precision of miRNA quantitation were determined for miRNA samples in a crude cell lysate, RNA extract from the lysate, and a pure buffer. The results showed that the measurements were matrix-independent with inaccuracies of below 13% from true values and relative standard deviations of below 11% from the mean values in a miRNA concentration range of 2 orders of magnitude. We compared DQAMmiR-derived results with those obtained by a benchmark miRNA-quantitation method–quantitative reverse transcription-polymerase chain reaction (qRT-PCR). qRT-PCR-based measurements revealed multifold inaccuracies and relative standard deviations of up to 70% in crude cell lysate. Robustness of DQAMmiR to changes in sample matrix makes it a perfect candidate for validation and clinical use of miRNA-based disease biomarkers.
- Open Access
- 17 November 2016
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 117,p. e54719
Automated Quantification and Analysis of Cell Counting Procedures Using ImageJ Plugins
This paper describes the quantification of hemocytometer and migration/invasion micrographs through two new open-source ImageJ plugins...
- 17 November 2016
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 117,p. e54719
Open AccessAutomated Quantification and Analysis of Cell Counting Procedures Using ImageJ Plugins
This paper describes the quantification of hemocytometer and migration/invasion micrographs through two new open-source ImageJ plugins...
- Open Access
- 8 March 2013
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 14 (3) , 5519-5544
MicroRNAs in Human Placental Development and Pregnancy Complications
MicroRNAs (miRNAs) are small non-coding RNAs, which function as critical posttranscriptional regulators of gene expression by promoting mRNA degradation and translational inhibition. Placenta expresses many ubiquitous as well as specific miRNAs. These miRNAs regulate trophoblast cell differentiation, proliferation, apoptosis, invasion/migration, and angiogenesis, suggesting that miRNAs play important roles during placental development. Aberrant miRNAs expression has been linked to pregnancy complications, such as preeclampsia. Recent research of placental miRNAs focuses on identifying placental miRNA species, examining differential expression of miRNAs between placentas from normal and compromised pregnancies, and uncovering the function of miRNAs in the placenta. More studies are required to further understand the functional significance of miRNAs in placental development and to explore the possibility of using miRNAs as biomarkers and therapeutic targets for pregnancy-related disorders. In this paper, we reviewed the current knowledge about the expression and function of miRNAs in placental development, and propose future directions for miRNA studies.
- 8 March 2013
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 14 (3) , 5519-5544
Open AccessMicroRNAs in Human Placental Development and Pregnancy Complications
MicroRNAs (miRNAs) are small non-coding RNAs, which function as critical posttranscriptional regulators of gene expression by promoting mRNA degradation and translational inhibition. Placenta expresses many ubiquitous as well as specific miRNAs. These miRNAs regulate trophoblast cell differentiation, proliferation, apoptosis, invasion/migration, and angiogenesis, suggesting that miRNAs play important roles during placental development. Aberrant miRNAs expression has been linked to pregnancy complications, such as preeclampsia. Recent research of placental miRNAs focuses on identifying placental miRNA species, examining differential expression of miRNAs between placentas from normal and compromised pregnancies, and uncovering the function of miRNAs in the placenta. More studies are required to further understand the functional significance of miRNAs in placental development and to explore the possibility of using miRNAs as biomarkers and therapeutic targets for pregnancy-related disorders. In this paper, we reviewed the current knowledge about the expression and function of miRNAs in placental development, and propose future directions for miRNA studies.